Shanghai Kehua Bio-Engineering Co.,Ltd (SHE:002022)
5.68
-0.08 (-1.39%)
Oct 19, 2026, 3:04 PM CST
SHE:002022 Revenue
Shanghai Kehua Bio-Engineering Co.,Ltd had revenue of 442.42M CNY in the quarter ending June 30, 2026, with 9.05% growth. This brings the company's total for the last twelve months to 1.69B, up 2.57% year-over-year. In the year 2025, Shanghai Kehua Bio-Engineering Co.,Ltd had annual revenue of 1.64B, down -6.63%. That makes Shanghai Kehua Bio-Engineering Co.,Ltd the 15,745th largest company in the world by revenue and 2,828th in China.
Revenue (ttm)
1.69B
Revenue Growth
+2.57%
P/S Ratio
1.74
Revenue / Employee
901.83K
Employees
1,870
Market Cap
2.94B
Revenue by Geography
- China 1.18B 71.8%
- Foreign 463.40M 28.2%
Fiscal year ended Dec 31, 2025 See the full SHE:002022 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.64B | -116.71M | -6.63% |
| Dec 31, 2024 | 1.76B | -668.88M | -27.55% |
| Dec 31, 2023 | 2.43B | -4.54B | -65.16% |
| Dec 31, 2022 | 6.97B | 2.12B | 43.58% |
| Jan 1, 2022 | 4.85B | 698.88M | 16.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Guangdong Biolight Meditech | 1.10B |
| Guangdong Transtek Medical Electronics | 999.28M |
| Chison Medical Technologies | 441.10M |
| Medprin Regenerative Medical Technologies | 400.85M |
| Tellgen | 392.11M |
| Shanghai General Healthy Information and Technology | 371.61M |
| CareRay Digital Medical Technology | 319.79M |
| Beijing Leadman Biochemistry | 317.79M |